DOE Decision On Health Records Draws Challenges From Skeptics

The U.S. Department of Energy may well have expected applause when it announced in June that it would allow independent researchers to analyze the health records of workers at the nation's nuclear reactors and weapons facilities. After all, the decision was meant to address the public's growing concern about the environmental impact of the nation's 45-year experience with nuclear materials. At the same time, the decision would reverse a long-time DOE policy of restricting access to its employees

Written byBarbara Spector
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

But the general response to a June 13 letter from Energy Secretary James Watkins to Sen. John Glenn (D-Ohio) has been something less than wild enthusiasm. Health activists have questioned DOE's motives in making the announcement, and they accuse the department of creating an elaborate, lengthy, and costly mechanism that will stymie rather than foster research. Glenn wants another federal agency to oversee any such analysis. And most scientists say that, although it sounds like a good idea, they plan to withhold final judgment until the details are clear.

"I'll be the first person to eat my hat if they release it [employee health information] in any usable form and in any reasonable time period," says Jonathan Berger, executive secretary of the Three Mile Island Public Health Fund, a non-profit group set up to conduct radiation studies after the 1979 accident at the Pennsylvania nuclear plant. "They're afraid of open ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies